A remote, algorithm-based programme to manage uncontrolled low-density lipoprotein (LDL) cholesterol and/or blood pressure is an effective and efficient way to optimise guideline-directed therapy across large populations, without the need for in-person visits .
The study results were presented by Prof. Benjamin Scirica (Brigham and Women's Hospital, USA) and simultaneously published in Circulation [1,2]. Prof. Scirica explained that undertreatment of hypercholesterolaemia and hypertension remains a problem. Thus, a remotely delivered, algorithmically-driven disease management programme was designed and implemented. In this programme, navigators and pharmacists, supported by specialists, initiated and titrated medications. Between January 2018 and May 2020, a total of 5,000 patients were enrolled in the cholesterol and hypertension programmes. During the COVID-19 pandemic, enrolment increased by nearly a quarter.
Among the 3,939 patients ...
Please login to read the full text of the article.
If you have no account yet, please register now.
« Healthy lifestyle lowers mortality irrespective of medication burden Next Article
Safety and efficacy of inclisiran for hypercholesterolemia »